UPLIZNA Approved In Brazil For The Treatment Of Neuromyelitis Optica Spectrum Disorder
-- First and only anti-CD19 B-cell-depleting monotherapy for the treatment of adult patients with NMOSD who are anti-aquaporin-4 immunoglobulin G seropositive (AQP4-IgG+) --
-- NMOSD is a devastating rare